Financials
Daiichi Sankyo: FYE Mar 2026 and ten years of results (46 metrics)
FYE Mar 2026 · Revenue¥2.12tnYoY +12.6%
FYE Mar 2026 · Operating profit¥229bnYoY −31.0%
FYE Mar 2026 · Net profit¥260bnYoY −12.1%
FYE Mar 2026 · Equity ratio41.5%YoY −5.4pp
FYE Mar 2026 · Group employees20,171YoY +406
| Fiscal year | Revenue | YoY | Operating profit | YoY | Margin | Net profit | Chief executive | That year |
|---|---|---|---|---|---|---|---|---|
| FYE Mar 2017Consolidated | ¥955bn | n/a | ¥89bn | n/a | 9.3% | ¥53bn | Nakayama Joji | — |
| FYE Mar 2018Consolidated | ¥960bn | +0.5% | ¥76bn | −14.2% | 7.9% | ¥60bn | Nakayama Joji | <a class="en-history_person" href="/tse/4568/executives/ceo/manabe-sunao/" hreflang="ja">Manabe Sunao</a> becomes president; a mid-term plan targets ¥165 billion of operating profit |
| FYE Mar 2019Consolidated | ¥930bn | −3.2% | ¥84bn | +9.7% | 9.0% | ¥93bn | Manabe Sunao | Revenue of ¥960.1 billion — barely above the level of a decade earlier |
| FYE Mar 2020Consolidated | ¥982bn | +5.6% | ¥139bn | +65.8% | 14.1% | ¥129bn | Manabe Sunao | AstraZeneca alliance on DS-8201 — up to $6.9 billion |
| FYE Mar 2021Consolidated | ¥963bn | −2.0% | ¥64bn | −54.0% | 6.6% | ¥76bn | Manabe Sunao | Enhertu launches in the US (January) and Japan (May) |
| FYE Mar 2022Consolidated | ¥1.04tn | +8.6% | ¥73bn | +14.5% | 7.0% | ¥67bn | Manabe Sunao | — |
| FYE Mar 2023Consolidated | ¥1.28tn | +22.4% | ¥121bn | +65.1% | 9.4% | ¥109bn | Manabe Sunao | Market capitalisation of ~¥6.9 trillion — first among Japanese drugmakers |
| FYE Mar 2024Consolidated | ¥1.60tn | +25.3% | ¥212bn | +75.5% | 13.2% | ¥201bn | Manabe Sunao | Merck & Co. alliance on three DXd ADCs |
| FYE Mar 2025Consolidated | ¥1.89tn | +17.8% | ¥332bn | +56.9% | 17.6% | ¥296bn | Okuzawa Hiroyuki | — |
| FYE Mar 2026Consolidated | ¥2.12tn | +12.6% | ¥229bn | −31.0% | 10.8% | ¥260bn | Okuzawa Hiroyuki | Datroway, the second DXd ADC, approved in Japan, the US and Europe |
How it compares
Takeda Pharmaceutical¥4.51tnFY2025Operating margin 0.1%Otsuka Holdings¥2.47tnFY2025Operating margin 19.4%Astellas Pharma¥2.14tnFY2025Operating margin 17.9%
Daiichi Sankyo¥2.12tnFY2025Operating margin 10.8%
Chugai Pharmaceutical¥1.26tnFY2025Operating margin 47.6%Eisai¥825bnFY2025Operating margin 5.3%Yamanouchi Pharmaceutical Co., Ltd.Dissolved 2005
Shionogi¥500bnFY2025Operating margin 33.4%Sumitomo Pharma¥453bnFY2025Operating margin 23.7%Mitsubishi Tanabe Pharma CorporationDissolved 2020
Income statement Revenue, costs, each level of profit and the margins they leave
Where the revenue goes
¥ bnMargins
%Revenue net sales, operating revenue
FYE Mar 2026 ¥2.12tn
CAGR · 10 yrs +9.3%
| Fiscal year | Revenue ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 955 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 960 | +0.5% | Cons. · IFRS |
| FYE Mar 2019 | 930 | −3.2% | Cons. · IFRS |
| FYE Mar 2020 | 982 | +5.6% | Cons. · IFRS |
| FYE Mar 2021 | 963 | −2.0% | Cons. · IFRS |
| FYE Mar 2022 | 1,045 | +8.6% | Cons. · IFRS |
| FYE Mar 2023 | 1,278 | +22.4% | Cons. · IFRS |
| FYE Mar 2024 | 1,602 | +25.3% | Cons. · IFRS |
| FYE Mar 2025 | 1,886 | +17.8% | Cons. · IFRS |
| FYE Mar 2026 | 2,123 | +12.6% | Cons. · IFRS |
Cost of sales
FYE Mar 2026 ¥669bn
CAGR · 10 yrs +7.5%
| Fiscal year | Cost of sales ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 349 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 346 | −1.0% | Cons. · IFRS |
| FYE Mar 2019 | 365 | +5.4% | Cons. · IFRS |
| FYE Mar 2020 | 343 | −5.9% | Cons. · IFRS |
| FYE Mar 2021 | 338 | −1.4% | Cons. · IFRS |
| FYE Mar 2022 | 353 | +4.4% | Cons. · IFRS |
| FYE Mar 2023 | 364 | +2.9% | Cons. · IFRS |
| FYE Mar 2024 | 415 | +14.2% | Cons. · IFRS |
| FYE Mar 2025 | 416 | +0.1% | Cons. · IFRS |
| FYE Mar 2026 | 669 | +60.9% | Cons. · IFRS |
Gross profit
FYE Mar 2026 ¥1.45tn
CAGR · 10 yrs +10.2%
| Fiscal year | Gross profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 606 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 614 | +1.4% | Cons. · IFRS |
| FYE Mar 2019 | 565 | −8.0% | Cons. · IFRS |
| FYE Mar 2020 | 639 | +13.0% | Cons. · IFRS |
| FYE Mar 2021 | 624 | −2.2% | Cons. · IFRS |
| FYE Mar 2022 | 691 | +10.8% | Cons. · IFRS |
| FYE Mar 2023 | 915 | +32.3% | Cons. · IFRS |
| FYE Mar 2024 | 1,186 | +29.7% | Cons. · IFRS |
| FYE Mar 2025 | 1,470 | +23.9% | Cons. · IFRS |
| FYE Mar 2026 | 1,454 | −1.1% | Cons. · IFRS |
SG&A selling, general and administrative expenses
FYE Mar 2026 ¥781bn
CAGR · 10 yrs +15.4%
| Fiscal year | SG&A ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 214 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 302 | +40.8% | Cons. · IFRS |
| FYE Mar 2019 | 278 | −8.0% | Cons. · IFRS |
| FYE Mar 2020 | 302 | +8.9% | Cons. · IFRS |
| FYE Mar 2021 | 333 | +10.2% | Cons. · IFRS |
| FYE Mar 2022 | 358 | +7.6% | Cons. · IFRS |
| FYE Mar 2023 | 471 | +31.5% | Cons. · IFRS |
| FYE Mar 2024 | 637 | +35.2% | Cons. · IFRS |
| FYE Mar 2025 | 731 | +14.8% | Cons. · IFRS |
| FYE Mar 2026 | 781 | +6.8% | Cons. · IFRS |
Operating profit
FYE Mar 2026 ¥229bn
CAGR · 10 yrs +11.1%
| Fiscal year | Operating profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 88.9 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 76.3 | −14.2% | Cons. · IFRS |
| FYE Mar 2019 | 83.7 | +9.7% | Cons. · IFRS |
| FYE Mar 2020 | 139 | +65.8% | Cons. · IFRS |
| FYE Mar 2021 | 63.8 | −54.0% | Cons. · IFRS |
| FYE Mar 2022 | 73.0 | +14.5% | Cons. · IFRS |
| FYE Mar 2023 | 121 | +65.1% | Cons. · IFRS |
| FYE Mar 2024 | 212 | +75.5% | Cons. · IFRS |
| FYE Mar 2025 | 332 | +56.9% | Cons. · IFRS |
| FYE Mar 2026 | 229 | −31.0% | Cons. · IFRS |
Non-operating income
FYE Mar 2026 ¥41bn
CAGR · 10 yrs +22.8%
| Fiscal year | Non-operating income ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 6.4 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 8.6 | +34.9% | Cons. · IFRS |
| FYE Mar 2019 | 8.1 | −5.8% | Cons. · IFRS |
| FYE Mar 2020 | 9.8 | +21.0% | Cons. · IFRS |
| FYE Mar 2021 | 12.9 | +31.1% | Cons. · IFRS |
| FYE Mar 2022 | 6.1 | −52.7% | Cons. · IFRS |
| FYE Mar 2023 | 14.8 | +141.6% | Cons. · IFRS |
| FYE Mar 2024 | 31.5 | +113.1% | Cons. · IFRS |
| FYE Mar 2025 | 34.1 | +8.3% | Cons. · IFRS |
| FYE Mar 2026 | 40.8 | +19.7% | Cons. · IFRS |
Non-operating expenses
FYE Mar 2026 ¥8.0bn
CAGR · 10 yrs +0.4%
| Fiscal year | Non-operating expenses ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 7.7 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 4.2 | −45.2% | Cons. · IFRS |
| FYE Mar 2019 | 5.9 | +39.9% | Cons. · IFRS |
| FYE Mar 2020 | 7.8 | +32.2% | Cons. · IFRS |
| FYE Mar 2021 | 2.8 | −64.7% | Cons. · IFRS |
| FYE Mar 2022 | 5.8 | +108.8% | Cons. · IFRS |
| FYE Mar 2023 | 8.5 | +47.4% | Cons. · IFRS |
| FYE Mar 2024 | 6.0 | −28.9% | Cons. · IFRS |
| FYE Mar 2025 | 11.9 | +96.7% | Cons. · IFRS |
| FYE Mar 2026 | 8.0 | −32.6% | Cons. · IFRS |
Net profit profit attributable to owners of the parent
FYE Mar 2026 ¥260bn
CAGR · 10 yrs +19.2%
| Fiscal year | Net profit ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 53.5 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 60.3 | +12.7% | Cons. · IFRS |
| FYE Mar 2019 | 93.4 | +55.0% | Cons. · IFRS |
| FYE Mar 2020 | 129 | +38.2% | Cons. · IFRS |
| FYE Mar 2021 | 76.0 | −41.2% | Cons. · IFRS |
| FYE Mar 2022 | 67.0 | −11.8% | Cons. · IFRS |
| FYE Mar 2023 | 109 | +63.0% | Cons. · IFRS |
| FYE Mar 2024 | 201 | +83.8% | Cons. · IFRS |
| FYE Mar 2025 | 296 | +47.3% | Cons. · IFRS |
| FYE Mar 2026 | 260 | −12.1% | Cons. · IFRS |
Gross margin
FYE Mar 2026 68.5%
Average · 10 yrs 67.6%
| Fiscal year | Gross margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 63.4 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 64.0 | +0.5pp | Cons. · IFRS |
| FYE Mar 2019 | 60.8 | −3.2pp | Cons. · IFRS |
| FYE Mar 2020 | 65.0 | +4.3pp | Cons. · IFRS |
| FYE Mar 2021 | 64.9 | −0.2pp | Cons. · IFRS |
| FYE Mar 2022 | 66.2 | +1.3pp | Cons. · IFRS |
| FYE Mar 2023 | 71.6 | +5.4pp | Cons. · IFRS |
| FYE Mar 2024 | 74.1 | +2.5pp | Cons. · IFRS |
| FYE Mar 2025 | 78.0 | +3.9pp | Cons. · IFRS |
| FYE Mar 2026 | 68.5 | −9.5pp | Cons. · IFRS |
Operating margin
FYE Mar 2026 10.8%
Average · 10 yrs 10.5%
| Fiscal year | Operating margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 9.3 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 7.9 | −1.4pp | Cons. · IFRS |
| FYE Mar 2019 | 9.0 | +1.1pp | Cons. · IFRS |
| FYE Mar 2020 | 14.1 | +5.1pp | Cons. · IFRS |
| FYE Mar 2021 | 6.6 | −7.5pp | Cons. · IFRS |
| FYE Mar 2022 | 7.0 | +0.4pp | Cons. · IFRS |
| FYE Mar 2023 | 9.4 | +2.4pp | Cons. · IFRS |
| FYE Mar 2024 | 13.2 | +3.8pp | Cons. · IFRS |
| FYE Mar 2025 | 17.6 | +4.4pp | Cons. · IFRS |
| FYE Mar 2026 | 10.8 | −6.8pp | Cons. · IFRS |
Net margin
FYE Mar 2026 12.2%
Average · 10 yrs 9.8%
| Fiscal year | Net margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 5.6 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 6.3 | +0.7pp | Cons. · IFRS |
| FYE Mar 2019 | 10.0 | +3.8pp | Cons. · IFRS |
| FYE Mar 2020 | 13.1 | +3.1pp | Cons. · IFRS |
| FYE Mar 2021 | 7.9 | −5.3pp | Cons. · IFRS |
| FYE Mar 2022 | 6.4 | −1.5pp | Cons. · IFRS |
| FYE Mar 2023 | 8.5 | +2.1pp | Cons. · IFRS |
| FYE Mar 2024 | 12.5 | +4.0pp | Cons. · IFRS |
| FYE Mar 2025 | 15.7 | +3.1pp | Cons. · IFRS |
| FYE Mar 2026 | 12.2 | −3.4pp | Cons. · IFRS |
Cost-of-sales ratio
FYE Mar 2026 31.5%
Average · 10 yrs 32.4%
| Fiscal year | Cost-of-sales ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 36.6 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 36.0 | −0.5pp | Cons. · IFRS |
| FYE Mar 2019 | 39.2 | +3.2pp | Cons. · IFRS |
| FYE Mar 2020 | 35.0 | −4.3pp | Cons. · IFRS |
| FYE Mar 2021 | 35.1 | +0.2pp | Cons. · IFRS |
| FYE Mar 2022 | 33.8 | −1.3pp | Cons. · IFRS |
| FYE Mar 2023 | 28.4 | −5.4pp | Cons. · IFRS |
| FYE Mar 2024 | 25.9 | −2.5pp | Cons. · IFRS |
| FYE Mar 2025 | 22.0 | −3.9pp | Cons. · IFRS |
| FYE Mar 2026 | 31.5 | +9.5pp | Cons. · IFRS |
SG&A ratio
FYE Mar 2026 36.8%
Average · 10 yrs 33.6%
| Fiscal year | SG&A ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 22.4 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 31.4 | +9.0pp | Cons. · IFRS |
| FYE Mar 2019 | 29.9 | −1.6pp | Cons. · IFRS |
| FYE Mar 2020 | 30.8 | +0.9pp | Cons. · IFRS |
| FYE Mar 2021 | 34.6 | +3.8pp | Cons. · IFRS |
| FYE Mar 2022 | 34.3 | −0.3pp | Cons. · IFRS |
| FYE Mar 2023 | 36.9 | +2.6pp | Cons. · IFRS |
| FYE Mar 2024 | 39.8 | +2.9pp | Cons. · IFRS |
| FYE Mar 2025 | 38.8 | −1.0pp | Cons. · IFRS |
| FYE Mar 2026 | 36.8 | −2.0pp | Cons. · IFRS |
Balance sheet Assets, debt and equity, and what they say about financial strength
What the balance sheet is made of
¥ bnFinancial strength
%Total assets
FYE Mar 2026 ¥4.01tn
CAGR · 10 yrs +8.5%
| Fiscal year | Total assets ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 1,915 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 1,898 | −0.9% | Cons. · IFRS |
| FYE Mar 2019 | 2,088 | +10.0% | Cons. · IFRS |
| FYE Mar 2020 | 2,106 | +0.8% | Cons. · IFRS |
| FYE Mar 2021 | 2,085 | −1.0% | Cons. · IFRS |
| FYE Mar 2022 | 2,221 | +6.5% | Cons. · IFRS |
| FYE Mar 2023 | 2,509 | +12.9% | Cons. · IFRS |
| FYE Mar 2024 | 3,461 | +38.0% | Cons. · IFRS |
| FYE Mar 2025 | 3,456 | −0.1% | Cons. · IFRS |
| FYE Mar 2026 | 4,005 | +15.9% | Cons. · IFRS |
Equity net assets, shareholders' equity
FYE Mar 2026 ¥1.66tn
CAGR · 10 yrs +3.9%
| Fiscal year | Equity ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 1,176 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 1,133 | −3.7% | Cons. · IFRS |
| FYE Mar 2019 | 1,250 | +10.3% | Cons. · IFRS |
| FYE Mar 2020 | 1,305 | +4.5% | Cons. · IFRS |
| FYE Mar 2021 | 1,272 | −2.6% | Cons. · IFRS |
| FYE Mar 2022 | 1,351 | +6.2% | Cons. · IFRS |
| FYE Mar 2023 | 1,446 | +7.0% | Cons. · IFRS |
| FYE Mar 2024 | 1,688 | +16.7% | Cons. · IFRS |
| FYE Mar 2025 | 1,623 | −3.8% | Cons. · IFRS |
| FYE Mar 2026 | 1,664 | +2.5% | Cons. · IFRS |
Interest-bearing debt
FYE Mar 2026 ¥300bn
CAGR · 10 yrs +0.8%
| Fiscal year | Interest-bearing debt ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 281 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 281 | −0.0% | Cons. · IFRS |
| FYE Mar 2019 | 261 | −7.1% | Cons. · IFRS |
| FYE Mar 2020 | 224 | −14.0% | Cons. · IFRS |
| FYE Mar 2021 | 184 | −18.0% | Cons. · IFRS |
| FYE Mar 2022 | 163 | −11.1% | Cons. · IFRS |
| FYE Mar 2023 | 143 | −12.5% | Cons. · IFRS |
| FYE Mar 2024 | 102 | −28.9% | Cons. · IFRS |
| FYE Mar 2025 | 101 | −0.4% | Cons. · IFRS |
| FYE Mar 2026 | 300 | +196.5% | Cons. · IFRS |
Short-term borrowings
FYE Mar 2026 ¥0.4bn
CAGR · 9 yrs −38.6%
| Fiscal year | Short-term borrowings ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 20.0 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 40.0 | +100.0% | Cons. · IFRS |
| FYE Mar 2020 | 40.4 | +1.0% | Cons. · IFRS |
| FYE Mar 2021 | 20.4 | −49.5% | Cons. · IFRS |
| FYE Mar 2022 | 20.4 | −0.0% | Cons. · IFRS |
| FYE Mar 2023 | 41.4 | +103.0% | Cons. · IFRS |
| FYE Mar 2024 | 0.4 | −99.0% | Cons. · IFRS |
| FYE Mar 2025 | 0.4 | −0.0% | Cons. · IFRS |
| FYE Mar 2026 | 0.4 | +1.3% | Cons. · IFRS |
Long-term borrowings
FYE Mar 2026 ¥300bn
CAGR · 10 yrs +0.8%
| Fiscal year | Long-term borrowings ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 281 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 261 | −7.1% | Cons. · IFRS |
| FYE Mar 2019 | 221 | −15.3% | Cons. · IFRS |
| FYE Mar 2020 | 184 | −16.7% | Cons. · IFRS |
| FYE Mar 2021 | 163 | −11.1% | Cons. · IFRS |
| FYE Mar 2022 | 143 | −12.5% | Cons. · IFRS |
| FYE Mar 2023 | 102 | −28.9% | Cons. · IFRS |
| FYE Mar 2024 | 101 | −0.4% | Cons. · IFRS |
| FYE Mar 2025 | 101 | −0.4% | Cons. · IFRS |
| FYE Mar 2026 | 300 | +197.3% | Cons. · IFRS |
Intangible assets
FYE Mar 2026 ¥241bn
CAGR · 9 yrs +4.2%
| Fiscal year | Intangible assets ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Cons. · IFRS |
| FYE Mar 2018 | 174 | n/a | Cons. · IFRS |
| FYE Mar 2019 | 169 | −2.3% | Cons. · IFRS |
| FYE Mar 2020 | 172 | +1.8% | Cons. · IFRS |
| FYE Mar 2021 | 173 | +0.2% | Cons. · IFRS |
| FYE Mar 2022 | 164 | −5.2% | Cons. · IFRS |
| FYE Mar 2023 | 160 | −2.6% | Cons. · IFRS |
| FYE Mar 2024 | 168 | +5.4% | Cons. · IFRS |
| FYE Mar 2025 | 236 | +40.1% | Cons. · IFRS |
| FYE Mar 2026 | 241 | +2.2% | Cons. · IFRS |
Goodwill
FYE Mar 2026 ¥97bn
CAGR · 10 yrs +2.4%
| Fiscal year | Goodwill ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 78.4 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 75.5 | −3.8% | Cons. · IFRS |
| FYE Mar 2019 | 77.9 | +3.1% | Cons. · IFRS |
| FYE Mar 2020 | 76.8 | −1.4% | Cons. · IFRS |
| FYE Mar 2021 | 77.7 | +1.2% | Cons. · IFRS |
| FYE Mar 2022 | 83.6 | +7.5% | Cons. · IFRS |
| FYE Mar 2023 | 98.3 | +17.7% | Cons. · IFRS |
| FYE Mar 2024 | 108 | +10.3% | Cons. · IFRS |
| FYE Mar 2025 | 108 | −0.1% | Cons. · IFRS |
| FYE Mar 2026 | 97.4 | −10.2% | Cons. · IFRS |
Equity ratio
FYE Mar 2026 41.5%
Average · 10 yrs 56.0%
| Fiscal year | Equity ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 61.4 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 59.7 | −1.7pp | Cons. · IFRS |
| FYE Mar 2019 | 59.8 | +0.1pp | Cons. · IFRS |
| FYE Mar 2020 | 62.0 | +2.1pp | Cons. · IFRS |
| FYE Mar 2021 | 61.0 | −1.0pp | Cons. · IFRS |
| FYE Mar 2022 | 60.8 | −0.2pp | Cons. · IFRS |
| FYE Mar 2023 | 57.6 | −3.2pp | Cons. · IFRS |
| FYE Mar 2024 | 48.8 | −8.9pp | Cons. · IFRS |
| FYE Mar 2025 | 47.0 | −1.8pp | Cons. · IFRS |
| FYE Mar 2026 | 41.5 | −5.4pp | Cons. · IFRS |
Debt-to-equity ratio D/E ratio
FYE Mar 2026 18.1%
Average · 10 yrs 15.3%
| Fiscal year | Debt-to-equity ratio % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 23.9 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 24.8 | +0.9pp | Cons. · IFRS |
| FYE Mar 2019 | 20.9 | −3.9pp | Cons. · IFRS |
| FYE Mar 2020 | 17.2 | −3.7pp | Cons. · IFRS |
| FYE Mar 2021 | 14.5 | −2.7pp | Cons. · IFRS |
| FYE Mar 2022 | 12.1 | −2.4pp | Cons. · IFRS |
| FYE Mar 2023 | 9.9 | −2.2pp | Cons. · IFRS |
| FYE Mar 2024 | 6.0 | −3.9pp | Cons. · IFRS |
| FYE Mar 2025 | 6.2 | +0.2pp | Cons. · IFRS |
| FYE Mar 2026 | 18.1 | +11.8pp | Cons. · IFRS |
ROE return on equity
FYE Mar 2026 15.6%
Average · 10 yrs 9.1%
| Fiscal year | ROE % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 4.5 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 5.3 | +0.8pp | Cons. · IFRS |
| FYE Mar 2019 | 7.5 | +2.2pp | Cons. · IFRS |
| FYE Mar 2020 | 9.9 | +2.4pp | Cons. · IFRS |
| FYE Mar 2021 | 6.0 | −3.9pp | Cons. · IFRS |
| FYE Mar 2022 | 5.0 | −1.0pp | Cons. · IFRS |
| FYE Mar 2023 | 7.6 | +2.6pp | Cons. · IFRS |
| FYE Mar 2024 | 11.9 | +4.3pp | Cons. · IFRS |
| FYE Mar 2025 | 18.2 | +6.3pp | Cons. · IFRS |
| FYE Mar 2026 | 15.6 | −2.6pp | Cons. · IFRS |
ROA return on assets
FYE Mar 2026 6.5%
Average · 10 yrs 4.8%
| Fiscal year | ROA % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 2.8 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 3.2 | +0.4pp | Cons. · IFRS |
| FYE Mar 2019 | 4.5 | +1.3pp | Cons. · IFRS |
| FYE Mar 2020 | 6.1 | +1.7pp | Cons. · IFRS |
| FYE Mar 2021 | 3.6 | −2.5pp | Cons. · IFRS |
| FYE Mar 2022 | 3.0 | −0.6pp | Cons. · IFRS |
| FYE Mar 2023 | 4.4 | +1.3pp | Cons. · IFRS |
| FYE Mar 2024 | 5.8 | +1.4pp | Cons. · IFRS |
| FYE Mar 2025 | 8.6 | +2.8pp | Cons. · IFRS |
| FYE Mar 2026 | 6.5 | −2.1pp | Cons. · IFRS |
Asset turnover
FYE Mar 2026 0.53×
CAGR · 10 yrs +0.7%
| Fiscal year | Asset turnover × | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 0.50 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 0.51 | +1.4% | Cons. · IFRS |
| FYE Mar 2019 | 0.45 | −12.0% | Cons. · IFRS |
| FYE Mar 2020 | 0.47 | +4.7% | Cons. · IFRS |
| FYE Mar 2021 | 0.46 | −1.0% | Cons. · IFRS |
| FYE Mar 2022 | 0.47 | +1.9% | Cons. · IFRS |
| FYE Mar 2023 | 0.51 | +8.3% | Cons. · IFRS |
| FYE Mar 2024 | 0.46 | −9.2% | Cons. · IFRS |
| FYE Mar 2025 | 0.55 | +17.9% | Cons. · IFRS |
| FYE Mar 2026 | 0.53 | −2.9% | Cons. · IFRS |
Cash flow statement Cash from operations, investment and financing, and what is left on hand
The three cash flows
¥ bnCash against debt
¥ bnOperating cash flow
FYE Mar 2026 ¥78bn
CAGR · 10 yrs −6.1%
| Fiscal year | Operating cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 136 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 108 | −20.4% | Cons. · IFRS |
| FYE Mar 2019 | 92.0 | −15.1% | Cons. · IFRS |
| FYE Mar 2020 | 197 | +113.6% | Cons. · IFRS |
| FYE Mar 2021 | 192 | −2.2% | Cons. · IFRS |
| FYE Mar 2022 | 139 | −27.6% | Cons. · IFRS |
| FYE Mar 2023 | 115 | −17.7% | Cons. · IFRS |
| FYE Mar 2024 | 599 | +423.3% | Cons. · IFRS |
| FYE Mar 2025 | 53.8 | −91.0% | Cons. · IFRS |
| FYE Mar 2026 | 77.7 | +44.2% | Cons. · IFRS |
Investing cash flow
FYE Mar 2026 -¥148bn
Average · 10 yrs -¥23bn
| Fiscal year | Investing cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | -96.8 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 109 | n/a | Cons. · IFRS |
| FYE Mar 2019 | -143 | −231.3% | Cons. · IFRS |
| FYE Mar 2020 | 81.7 | n/a | Cons. · IFRS |
| FYE Mar 2021 | -39.2 | −148.1% | Cons. · IFRS |
| FYE Mar 2022 | 212 | n/a | Cons. · IFRS |
| FYE Mar 2023 | -258 | −221.4% | Cons. · IFRS |
| FYE Mar 2024 | -283 | n/a | Cons. · IFRS |
| FYE Mar 2025 | 334 | n/a | Cons. · IFRS |
| FYE Mar 2026 | -148 | −144.4% | Cons. · IFRS |
Financing cash flow
FYE Mar 2026 -¥98bn
Average · 10 yrs -¥125bn
| Fiscal year | Financing cash flow ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | -15.0 | n/a | Cons. · IFRS |
| FYE Mar 2018 | -102 | n/a | Cons. · IFRS |
| FYE Mar 2019 | -66.2 | n/a | Cons. · IFRS |
| FYE Mar 2020 | -91.6 | n/a | Cons. · IFRS |
| FYE Mar 2021 | -202 | n/a | Cons. · IFRS |
| FYE Mar 2022 | -86.2 | n/a | Cons. · IFRS |
| FYE Mar 2023 | -89.6 | n/a | Cons. · IFRS |
| FYE Mar 2024 | -124 | n/a | Cons. · IFRS |
| FYE Mar 2025 | -378 | n/a | Cons. · IFRS |
| FYE Mar 2026 | -97.9 | n/a | Cons. · IFRS |
Cash and equivalents
FYE Mar 2026 ¥450bn
CAGR · 10 yrs +6.9%
| Fiscal year | Cash and equivalents ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 246 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 358 | +45.4% | Cons. · IFRS |
| FYE Mar 2019 | 243 | −32.0% | Cons. · IFRS |
| FYE Mar 2020 | 424 | +74.5% | Cons. · IFRS |
| FYE Mar 2021 | 381 | −10.3% | Cons. · IFRS |
| FYE Mar 2022 | 662 | +74.1% | Cons. · IFRS |
| FYE Mar 2023 | 442 | −33.3% | Cons. · IFRS |
| FYE Mar 2024 | 647 | +46.4% | Cons. · IFRS |
| FYE Mar 2025 | 640 | −1.1% | Cons. · IFRS |
| FYE Mar 2026 | 450 | −29.7% | Cons. · IFRS |
Free cash flow
FYE Mar 2026 -¥71bn
Average · 10 yrs ¥148bn
| Fiscal year | FCF ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 39.4 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 217 | +450.2% | Cons. · IFRS |
| FYE Mar 2019 | -50.5 | −123.3% | Cons. · IFRS |
| FYE Mar 2020 | 278 | n/a | Cons. · IFRS |
| FYE Mar 2021 | 153 | −45.0% | Cons. · IFRS |
| FYE Mar 2022 | 352 | +129.8% | Cons. · IFRS |
| FYE Mar 2023 | -143 | −140.8% | Cons. · IFRS |
| FYE Mar 2024 | 317 | n/a | Cons. · IFRS |
| FYE Mar 2025 | 388 | +22.5% | Cons. · IFRS |
| FYE Mar 2026 | -70.6 | −118.2% | Cons. · IFRS |
Operating cash flow margin
FYE Mar 2026 3.7%
Average · 10 yrs 14.2%
| Fiscal year | OCF margin % | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 14.3 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 11.3 | −3.0pp | Cons. · IFRS |
| FYE Mar 2019 | 9.9 | −1.4pp | Cons. · IFRS |
| FYE Mar 2020 | 20.0 | +10.1pp | Cons. · IFRS |
| FYE Mar 2021 | 20.0 | −0.1pp | Cons. · IFRS |
| FYE Mar 2022 | 13.3 | −6.6pp | Cons. · IFRS |
| FYE Mar 2023 | 9.0 | −4.4pp | Cons. · IFRS |
| FYE Mar 2024 | 37.4 | +28.5pp | Cons. · IFRS |
| FYE Mar 2025 | 2.9 | −34.6pp | Cons. · IFRS |
| FYE Mar 2026 | 3.7 | +0.8pp | Cons. · IFRS |
Net cash
FYE Mar 2026 ¥149bn
Average · 10 yrs ¥245bn
| Fiscal year | Net cash ¥ bn | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | -34.5 | n/a | Cons. · IFRS |
| FYE Mar 2018 | 77.1 | n/a | Cons. · IFRS |
| FYE Mar 2019 | -17.4 | −122.6% | Cons. · IFRS |
| FYE Mar 2020 | 200 | n/a | Cons. · IFRS |
| FYE Mar 2021 | 197 | −1.6% | Cons. · IFRS |
| FYE Mar 2022 | 499 | +153.7% | Cons. · IFRS |
| FYE Mar 2023 | 299 | −40.1% | Cons. · IFRS |
| FYE Mar 2024 | 545 | +82.5% | Cons. · IFRS |
| FYE Mar 2025 | 539 | −1.3% | Cons. · IFRS |
| FYE Mar 2026 | 149 | −72.3% | Cons. · IFRS |
Shares and share price Shares outstanding, price, market capitalisation and the valuation multiples
Market capitalisation
FYE Mar 2026 ¥5.24tn
Change · 10 yrs +¥3.46tn
| Fiscal year | Market capitalisation ¥ bn | Basis |
|---|---|---|
| FYE Mar 2017 | 1,778 | n/a |
| FYE Mar 2018 | 2,499 | n/a |
| FYE Mar 2019 | 3,620 | n/a |
| FYE Mar 2020 | 5,268 | n/a |
| FYE Mar 2021 | 6,857 | n/a |
| FYE Mar 2022 | 5,218 | n/a |
| FYE Mar 2023 | 9,393 | n/a |
| FYE Mar 2024 | 9,295 | n/a |
| FYE Mar 2025 | 6,696 | n/a |
| FYE Mar 2026 | 5,241 | n/a |
Share price year-end close
FYE Mar 2026 2,767¥
Change · 10 yrs +259¥
| Fiscal year | Share price ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 2,508 | n/a |
| FYE Mar 2018 | 3,525 | n/a |
| FYE Mar 2019 | 5,105 | n/a |
| FYE Mar 2020 | 7,430 | n/a |
| FYE Mar 2021 | 3,224 | n/a |
| FYE Mar 2022 | 2,680 | n/a |
| FYE Mar 2023 | 4,825 | n/a |
| FYE Mar 2024 | 4,774 | n/a |
| FYE Mar 2025 | 3,509 | n/a |
| FYE Mar 2026 | 2,767 | n/a |
EPS earnings per share
FYE Mar 2026 140.44¥
Change · 10 yrs +113.90¥
| Fiscal year | EPS ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 26.54 | Cons. |
| FYE Mar 2018 | 30.44 | Cons. |
| FYE Mar 2019 | 48.07 | Cons. |
| FYE Mar 2020 | 66.40 | Cons. |
| FYE Mar 2021 | 39.17 | Cons. |
| FYE Mar 2022 | 34.94 | Cons. |
| FYE Mar 2023 | 56.96 | Cons. |
| FYE Mar 2024 | 104.69 | Cons. |
| FYE Mar 2025 | 155.96 | Cons. |
| FYE Mar 2026 | 140.44 | Cons. |
BPS book value per share
FYE Mar 2026 878.50¥
Change · 10 yrs −780.01¥
| Fiscal year | BPS ¥ | Basis |
|---|---|---|
| FYE Mar 2017 | 1,658.50 | Cons. · IFRS |
| FYE Mar 2018 | 1,597.89 | Cons. · IFRS |
| FYE Mar 2019 | 1,762.43 | Cons. · IFRS |
| FYE Mar 2020 | 1,841.08 | Cons. · IFRS |
| FYE Mar 2021 | 598.04 | Cons. · IFRS |
| FYE Mar 2022 | 693.81 | Cons. · IFRS |
| FYE Mar 2023 | 742.59 | Cons. · IFRS |
| FYE Mar 2024 | 866.83 | Cons. · IFRS |
| FYE Mar 2025 | 850.70 | Cons. · IFRS |
| FYE Mar 2026 | 878.50 | Cons. · IFRS |
PER price-to-earnings ratio
FYE Mar 2026 19.70×
Average · 10 yrs 47.43×
| Fiscal year | PER × | Basis |
|---|---|---|
| FYE Mar 2017 | 31.50 | Cons. |
| FYE Mar 2018 | 38.60 | Cons. |
| FYE Mar 2019 | 35.40 | Cons. |
| FYE Mar 2020 | 37.30 | Cons. |
| FYE Mar 2021 | 82.30 | Cons. |
| FYE Mar 2022 | 76.70 | Cons. |
| FYE Mar 2023 | 84.70 | Cons. |
| FYE Mar 2024 | 45.60 | Cons. |
| FYE Mar 2025 | 22.50 | Cons. |
| FYE Mar 2026 | 19.70 | Cons. |
PBR price-to-book ratio
FYE Mar 2026 3.03×
Average · 10 yrs 3.73×
| Fiscal year | PBR × | Basis |
|---|---|---|
| FYE Mar 2017 | 1.41 | Cons. |
| FYE Mar 2018 | 2.02 | Cons. |
| FYE Mar 2019 | 2.65 | Cons. |
| FYE Mar 2020 | 3.69 | Cons. |
| FYE Mar 2021 | 4.86 | Cons. |
| FYE Mar 2022 | 3.80 | Cons. |
| FYE Mar 2023 | 6.40 | Cons. |
| FYE Mar 2024 | 5.42 | Cons. |
| FYE Mar 2025 | 4.03 | Cons. |
| FYE Mar 2026 | 3.03 | Cons. |
Workforce and productivity Headcount, pay and what each employee accounts for
Group employees
FYE Mar 2026 20,171people
Change · 10 yrs +5,501 people
| Fiscal year | Group employees people | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 14,670 | n/a | Cons. |
| FYE Mar 2018 | 14,446 | −1.5% | Cons. |
| FYE Mar 2019 | 14,887 | +3.1% | Cons. |
| FYE Mar 2020 | 15,348 | +3.1% | Cons. |
| FYE Mar 2021 | 16,033 | +4.5% | Cons. |
| FYE Mar 2022 | 16,458 | +2.7% | Cons. |
| FYE Mar 2023 | 17,435 | +5.9% | Cons. |
| FYE Mar 2024 | 18,726 | +7.4% | Cons. |
| FYE Mar 2025 | 19,765 | +5.5% | Cons. |
| FYE Mar 2026 | 20,171 | +2.1% | Cons. |
Parent-company employees
FYE Mar 2026 8,009people
Change · 10 yrs +2,699 people
| Fiscal year | Parent-company employees people | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 5,310 | n/a | Parent |
| FYE Mar 2018 | 5,357 | +0.9% | Parent |
| FYE Mar 2019 | 5,515 | +2.9% | Parent |
| FYE Mar 2020 | 5,600 | +1.5% | Parent |
| FYE Mar 2021 | 5,703 | +1.8% | Parent |
| FYE Mar 2022 | 5,725 | +0.4% | Parent |
| FYE Mar 2023 | 5,756 | +0.5% | Parent |
| FYE Mar 2024 | 5,817 | +1.1% | Parent |
| FYE Mar 2025 | 6,252 | +7.5% | Parent |
| FYE Mar 2026 | 8,009 | +28.1% | Parent |
Average annual pay parent company
FYE Mar 2026 ¥11.0m
Change · 10 yrs −¥0.4m
| Fiscal year | Average annual pay ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 11.3 | n/a | Parent |
| FYE Mar 2018 | 11.0 | −2.6% | Parent |
| FYE Mar 2019 | 11.0 | −0.5% | Parent |
| FYE Mar 2020 | 11.3 | +2.6% | Parent |
| FYE Mar 2021 | 11.2 | −0.9% | Parent |
| FYE Mar 2022 | 10.9 | −2.0% | Parent |
| FYE Mar 2023 | 11.2 | +2.3% | Parent |
| FYE Mar 2024 | 11.1 | −0.6% | Parent |
| FYE Mar 2025 | 11.1 | +0.1% | Parent |
| FYE Mar 2026 | 11.0 | −1.5% | Parent |
Average age
FYE Mar 2026 45.0years
Change · 8 yrs +2.0 years
| Fiscal year | Average age years | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | n/a | n/a | Parent |
| FYE Mar 2018 | n/a | n/a | Parent |
| FYE Mar 2019 | 43.0 | n/a | Parent |
| FYE Mar 2020 | 42.9 | −0.2% | Parent |
| FYE Mar 2021 | 44.4 | +3.5% | Parent |
| FYE Mar 2022 | 44.8 | +0.9% | Parent |
| FYE Mar 2023 | 45.3 | +1.1% | Parent |
| FYE Mar 2024 | 45.5 | +0.4% | Parent |
| FYE Mar 2025 | 46.0 | +1.1% | Parent |
| FYE Mar 2026 | 45.0 | −2.2% | Parent |
Average length of service
FYE Mar 2026 19.9years
Change · 10 yrs +1.1 years
| Fiscal year | Average length of service years | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 18.8 | n/a | Parent |
| FYE Mar 2018 | 18.5 | −1.6% | Parent |
| FYE Mar 2019 | 18.9 | +2.2% | Parent |
| FYE Mar 2020 | 18.6 | −1.6% | Parent |
| FYE Mar 2021 | 19.6 | +5.4% | Parent |
| FYE Mar 2022 | 20.0 | +2.0% | Parent |
| FYE Mar 2023 | 20.3 | +1.5% | Parent |
| FYE Mar 2024 | 20.3 | −0.0% | Parent |
| FYE Mar 2025 | 20.3 | −0.0% | Parent |
| FYE Mar 2026 | 19.9 | −2.0% | Parent |
Revenue per employee
FYE Mar 2026 ¥105m
Change · 10 yrs +¥40.1m
| Fiscal year | Revenue per employee ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 65.1 | n/a | Cons. |
| FYE Mar 2018 | 66.5 | +2.1% | Cons. |
| FYE Mar 2019 | 62.5 | −6.0% | Cons. |
| FYE Mar 2020 | 64.0 | +2.4% | Cons. |
| FYE Mar 2021 | 60.0 | −6.2% | Cons. |
| FYE Mar 2022 | 63.5 | +5.8% | Cons. |
| FYE Mar 2023 | 73.3 | +15.5% | Cons. |
| FYE Mar 2024 | 85.5 | +16.6% | Cons. |
| FYE Mar 2025 | 95.4 | +11.6% | Cons. |
| FYE Mar 2026 | 105 | +10.3% | Cons. |
Operating profit per employee
FYE Mar 2026 ¥11.4m
Change · 10 yrs +¥5.3m
| Fiscal year | OP per employee ¥ m | YoY | Basis |
|---|---|---|---|
| FYE Mar 2017 | 6.1 | n/a | Cons. |
| FYE Mar 2018 | 5.3 | −12.9% | Cons. |
| FYE Mar 2019 | 5.6 | +6.5% | Cons. |
| FYE Mar 2020 | 9.0 | +60.8% | Cons. |
| FYE Mar 2021 | 4.0 | −56.0% | Cons. |
| FYE Mar 2022 | 4.4 | +11.5% | Cons. |
| FYE Mar 2023 | 6.9 | +55.9% | Cons. |
| FYE Mar 2024 | 11.3 | +63.4% | Cons. |
| FYE Mar 2025 | 16.8 | +48.6% | Cons. |
| FYE Mar 2026 | 11.4 | −32.4% | Cons. |
Disclaimer
- Figures are reproduced as filed and are not restated: a change of accounting standard or of consolidation basis moves the series without anything happening to the business. Where that happened, the table says so in place of the year-on-year figure.
- Ratios and per-employee figures are computed from the filed lines rather than taken from the filing, and use year-end balances rather than averages.
Accuracy, liability, reuse and privacy — the full disclaimer →
Data API
Daiichi Sankyo’s history, presidents and financials
are published as static JSON — no key, plain GET. One API per
public page, and one per section where a page carries several tables.
Full specification →
/api/4568/company.json ·/api/4568/history.json ·/api/4568/ceo.json ·/api/4568/financials.json ·/api/4568/financials/segment.json ·/api/4568/financials/pl.json ·/api/4568/financials/cf.json ·/api/4568/financials/bs.json ·/api/4568/financials/employee.json ·/api/4568/financials/stock.json ·/api/4568/financials.csv ·/api/4568/financials_history.csv
/api/companies.json ·/api/decisions.json ·/api/api-manifest.json